The divide between the self-care market and the healthcare market causes friction for women. Accessing products and services ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

"I could once again complete a coherent sentence and wasn’t so inexplicably angry that I was biting people’s heads off simply ...